1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities

1/2 U-HAND（休斯顿大学/MD 安德森大学）减少癌症差异的计划

基本信息

批准号：
10268472
负责人：
Lorraine R Reitzel
金额：
$ 5.1万
依托单位：
UNIVERSITY OF HOUSTON
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-22 至 2022-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10268472
关键词：
Achievement Acute Address Adherence Administrative Supplement Admission activity Adoption Affect Algorithms Biological Breast Cancer Patient Breast Cancer Treatment COVID-19 COVID-19 pandemic Cancer Center Cancer Model Cancer Patient Caring Cessation of life Characteristics Clinical Communities Continuity of Patient Care Data Development Diagnosis Disease Disease Outbreaks Distal Early treatment Emergency Situation Environment Ethnic group Family Caregiver Fostering Future General Population Goals Grant Hand Health Health Professional Hispanics Hurricane Immunocompromised Host Incidence Individual Infection Insurance Intensive Care Units Interruption Intervention Literature Local Therapy Maintenance Malignant Neoplasms Measures Medical Medical Care Costs Mentors Minority Minority Groups Mission Modification Natural Disasters Not Hispanic or Latino Operative Surgical Procedures Outcome Participant Pathway interactions Patient Care Patient-Focused Outcomes Patients Play Policies Protocols documentation Quality of Care Quality of life Radiation therapy Recommendation Recurrence Reporting Research Resources Risk Risk Behaviors Role Screening for cancer Service delivery model Severe Acute Respiratory Syndrome Social Network Socioeconomic Factors Time Training Activity Treatment Protocols Triage Unemployment Universities University of Texas M D Anderson Cancer Center Viral Vulnerable Populations Woman adjuvant endocrine therapy adverse outcome behavioral/social science burden of illness cancer care cancer health disparity cancer therapy care delivery care outcomes career ethnic minority population experience health care availability health care service utilization health care settings health equity health related quality of life high risk improved innovation malignant breast neoplasm member mortality novel pandemic disease prevent programs psychosocial racial and ethnic racial minority screening skills social social health determinants sociodemographic variables survivorship tumor

项目摘要

PROJECT SUMMARY/ABSTRACT The unprecedented burden of the COVID-19 pandemic has critical consequences for the delivery of cancer care: patients present greater vulnerability to the disease and newly implemented treatment pathways and protocols may affect long-term survival because of suboptimal or delayed care. For racial and ethnic minority women receiving treatment for breast cancer, institutional measures implemented to regulate access of patients to medical settings and modifications in therapy sequence may exacerbate the existing disproportionate burden of the disease. Therefore, understanding the impact of COVID-19 on the cancer care received by minority groups and identifying potentially modifiable factors to inform future models of care delivery is critical. The U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities (P20CA221697; 9/22/17-8/31/21) is a collaborative partnership between the University of Houston and The University of Texas MD Anderson Cancer Center that supports excellence in educational programming and innovation in research that affects health equity among racial/ethnic groups disproportionately affected by cancer disparities. The proposed Administrative Supplement application is a natural extension of the aims of the UHAND partnership and it is reflective of its overarching mission to execute innovative social/behavioral science aimed at mitigating cancer inequities for Black and Hispanic groups. Specifically, the proposed Supplement will be an extension of this goal by investigating the impact that the COVID-19 pandemic has on the receipt of optimal breast cancer care among women from racial and ethnic communities disproportionately affected by the illness and its psychosocial sequelae. This proposal is a logical next step building upon the Administrative Applicant’s expertise on the intermediate determinants of cancer-related outcomes. Pilot data collected will assess differential rates of cancer care disruption and health-related quality of life among Black and Hispanic women diagnosed with early-stage breast cancer (as compared with non-Hispanic white women), and examine how proximal, intermediate, and distal determinants of disparities contribute to these outcomes. It is envisioned that the study will yield information about “at-risk” patients and ways to leverage existing social resources. Finally, these findings will be used to inform future multilevel interventions able to sustain effective models of care delivery in a post-acute COVID-19 environment. During the one-year Administrative Supplement grant period, research and mentored training activities will help the applicant complete the research aims of the proposed project, and develop skills that will support her understanding of mechanisms that contribute to disparities in both health care utilization and outcomes among diverse groups to foster a successful career in reducing and eliminating cancer disparities.

项目概要/摘要 COVID-19 大流行带来的前所未有的负担对癌症的发生产生了严重后果护理：患者更容易受到这种疾病的影响，并且新实施的治疗途径和由于少数种族和族裔的护理欠佳或延迟，方案可能会影响长期生存。接受乳腺癌治疗的妇女，为规范获得治疗而采取的制度措施患者接受医疗环境和治疗顺序的修改可能会使现有的情况恶化因此，了解 COVID-19 对癌症护理的影响。少数群体接受并确定潜在的可改变因素，为未来的护理模式提供信息 U-HAND（休斯顿大学/MD 安德森大学）减少癌症差异计划至关重要。（P20CA221697；9/22/17-8/31/21）是休斯顿大学和德克萨斯大学 MD 安德森癌症中心支持卓越的教育和规划影响种族/族裔群体公平健康的研究创新，其影响尤为严重拟议的行政补充申请是目标的自然延伸。 UHAND 合作伙伴关系反映了其执行创新社会/行为的总体使命具体而言，该科学旨在减轻黑人和西班牙裔群体的癌症不平等。补充文件将通过调查 COVID-19 大流行对企业的影响来扩展这一目标来自种族和族裔社区的妇女获得最佳乳腺癌护理的比例不成比例该提议是建立在该疾病及其社会心理后遗症的基础上的合乎逻辑的下一步。行政申请人在癌症相关结果的中间决定因素方面的专业知识。收集的数据将评估黑人癌症护理中断率和健康相关生活质量的差异以及被诊断患有早期乳腺癌的西班牙裔女性（与非西班牙裔白人女性相比），并研究差异的近端、中间和远端决定因素如何影响这些结果。预计该研究将提供有关“高危”患者的信息以及利用现有社会的方法最后，这些发现将用于为未来能够维持有效的多层次干预措施提供信息。一年行政期间急性后 COVID-19 环境中的护理提供模式。补充资助期、研究和指导培训活动将帮助申请人完成拟议项目的研究目标，并培养支持她理解机制的技能这导致了不同群体之间医疗保健利用和结果的差异，从而促进了在减少和消除癌症差异方面取得了成功。